Abstract:
General Background: The development of heterocyclic compounds, particularly dihydropyrimidine derivatives, has garnered considerable interest due to their broad pharmacological potential. Specific Background: Among these, thioxo-dihydropyrimidines have demonstrated significant bioactivity, including anticancer and antimicrobial properties. Knowledge Gap: However, efficient synthesis methods and biocompatibility assessments for novel thioxo-dihydropyrimidines remain limited. Aims: This study aims to synthesize and characterize a new compound, [(6S)-6-(2-hydroxyphenyl)-5-methoxy-2-thioxo-1,2,3,6-tetrahydropyrimidine-4-carbonitrile], and evaluate its cytotoxic potential on human red blood cells. Results: The compound was synthesized via a one-pot multi-component reaction using 2-hydroxybenzaldehyde, methyl cyanoacetate, and thiourea with ferric (III) chloride and HCl in ethanol, yielding 80% of a light golden solid (m.p. 222–224°C). Characterization was confirmed through FT-IR, ¹H-NMR, and MS analysis. Cytotoxicity tests showed the compound to be non-toxic at tested concentrations (0.1–0.5 mg/mL), as evidenced by minimal hemolytic activity. Novelty: This study presents a novel synthetic route for a thioxo-dihydropyrimidine derivative with confirmed structural integrity and biocompatibility. Implications: These findings highlight the potential of this compound as a safe scaffold for future drug development, especially in therapeutic applications requiring low cytotoxic profiles.
Highlights:
- Thioxo-dihydropyrimidines show promise in biomedical applications.
- Synthesized novel compound; confirmed structure; non-toxic to red blood cells.
- Potential safe scaffold for future drug development.
Keywards: Dihydropyrimidine , Thiourea, Spectra, Cyanoacetate, 1H-NMR
References
S. Sandhu and J. S. Sandhu, “Past, Present and Future of the Biginelli Reaction: A Critical Perspective,” ChemInform, vol. 10, pp. 66–133, 2012.
B. Mohammadi and F. K. Behbahani, “Recent Developments in the Synthesis and Applications of Dihydropyrimidin-2(1H)-ones and Thiones,” Molecular Diversity, vol. 22, pp. 405–446, 2018.
L. H. Santana-Matos, F. T. Masson, L. A. Simeoni, and M. Homem-de-Mello, “Biological Activity of Dihydropyrimidinone (DHPM) Derivatives: A Systematic Review,” European Journal of Medicinal Chemistry, vol. 143, pp. 1779–1789, 2018.
Khan et al., “Dihydropyrimidine Based Hydrazine Dihydrochloride Derivatives as Potent Urease Inhibitors,” Bioorganic Chemistry, vol. 69, pp. 1–7, 2016.
S. Khasimbi, F. Ali, K. Manda, A. Sharma, G. Chauhan, and S. Wakode, “Dihydropyrimidinones Scaffold as a Promising Nucleus for Synthetic Profile and Various Therapeutic Targets: A Review,” Current Organic Synthesis, vol. 18, pp. 270–293, 2021.
T. K. Jeena, M. George, and L. Joseph, “A Systematic Review on the Recent Advances in the Pharmacological Activities of Dihydropyrimidinones,” Chemical Research Journal, vol. 4, pp. 19–23, 2019.
S. Ahmad et al., “Rational Design and Synthesis of Dihydropyrimidine Based Dual Binding Site Acetylcholinesterase Inhibitors,” Bioorganic Chemistry, vol. 69, pp. 60–70, 2016.
H. A. Stefani et al., “Dihydropyrimidin-(2H)-ones Obtained by Ultrasound Irradiation: A New Class of Potential Antioxidant Agents,” European Journal of Medicinal Chemistry, vol. 41, no. 4, pp. 513–518, 2006.
P. Biginelli, “Synthesis of 3,4-Dihydropyrimidin-2(1H)-ones,” Gazzetta Chimica Italiana, vol. 23, pp. 360–416, 1893.
G. C. Tron, A. Minassi, and G. Appendino, “Pietro Biginelli: The Man Behind the Reaction,” European Journal of Organic Chemistry, vol. 2011, no. 28, pp. 5541–5550, 2011.
X. Chen and Y. Peng, “Chloroferrate (III) Ionic Liquid: Efficient and Recyclable Catalyst for Solvent-Free Synthesis of 3,4-Dihydropyrimidin-2-(1H)-ones,” Catalysis Letters, vol. 122, no. 3–4, pp. 310–313, 2008.
S. L. Jain, J. K. Joseph, and B. Sain, “Ionic Liquid Promoted an Improved Synthesis of 3,4-Dihydropyrimidinones Using [bmim]BF4 Immobilized Cu(II) Acetylacetonate as Recyclable Catalytic System,” Catalysis Letters, vol. 115, no. 1–2, pp. 52–55, 2007.
R. Velpula, J. Banothu, R. Gali, R. Deshineni, and R. Bavantula, “1-Sulfopyridinium Chloride: Green and Expeditious Ionic Liquid for the One-Pot Synthesis of Fused 3,4-Dihydropyrimidin-2-(1H)-ones and Thiones Under Solvent-Free Conditions,” Chinese Chemical Letters, vol. 26, no. 3, pp. 309–312, 2015.
B. Subhas, S. Madapa, and W. Sanjay, “Synthesis and Characterization of Novel Dihydropyrimidine Derivatives,” ARKIVOC, pp. 228–236, 2005.
C. O. Kappe, “A Reexamination of the Mechanism of the Biginelli Dihydropyrimidine Synthesis: Support for an N-Acyliminium Ion Intermediate,” Journal of Organic Chemistry, vol. 62, pp. 7201–7204, 1997.
K. Zaid, “Preparation, Characterization and Biological Activity of New Derivatives 1,3-Diazines,” Annals of R.S.C.B., vol. 25, no. 6, pp. 3417–3426, 2021.
R. C. Khunt, Thesis PhD, Saurashtra University, 2007.
C. O. Kappe, “Recent Advances in the Biginelli Reaction,” European Journal of Medicinal Chemistry, vol. 35, pp. 1043–1052, 2000.
R. Silverstein, F. Webster, and D. Kiemle, Spectrometric Identification of Organic Compounds, 7th ed., New York: John Wiley & Sons, 2005.
M. J. Hearn et al., “Preparation and Antitubercular Activities In Vitro and In Vivo of Novel Schiff Bases of Isoniazid,” European Journal of Medicinal Chemistry, vol. 44, pp. 4169–4178, 2009.
L. Latheef and M. P. S. Kurup, “Synthesis and Spectral Studies of 3-Azacyclothiosemicarbazones,” Journal of Advanced Scientific Research, vol. 10, pp. 333–338, 2019.
L. Cao, C. Wang, and D. Wang, “Synthesis and Evaluation of Novel Dihydropyrimidines,” Journal of the Chinese Chemical Society, vol. 53, pp. 1193–1197, 2006.
M. Beniwal and N. Jain, “Novel Approach for Rapid and Efficient Synthesis of 2-(3-(4-Aryl)-1-Isonicotinoyl-4,5-Dihydro-1H-Pyrazol-4-yl)-3-Phenylthiazolidin-4-one Derivatives and Screened Their Antimicrobial Activity,” Journal of Heterocyclic Chemistry, vol. 56, pp. 2508–2516, 2019.